4'-Methylbiphenyl-4-thiocarboxamide, 1g

1-(3-Chloropropyl)pyrrolidine hydrochloride, 95.0%, 10g

3-Allylrhodanine, 98%, 5g

(3aS,8bS)-4-(4-(2,2-diphenylvinyl)phenyl)-1,2,3,3a,4,8b-hexahydrocyclopenta[b]indole-7-carbaldehyde, 98%, 100mg

Methyl 4-(tert-butyl)-2-ethoxybenzoate, 95.0%, 1g

Hexanohydroxamic Acid, 98.0%, 5g

2-Benzyl-5-(chloromethyl)-1,3,4-oxadiazole, 95+%, 1g

1-(4-Fluorophenyl)biguanide hydrochloride, 97.0%, 100mg

2-(4-Amino-3-methylphenyl)-1,1,1,3,3,3-hexafluoropropan-2-ol, 95.0%, 100mg

1H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-6-one, 98%, 1g

(E)-1-Methoxy-4-(prop-1-en-1-yl)benzene, 95.0%, 500g

Colonna capillare per GC ROTI®Cap-1701, 50 m, 0.20 mm, 0.20 µm, 1 Pezzo(i)

2,6-BIS((R)-4-METHYL-4,5-DIHYDROOXAZOL-2-YL)PYRIDINE, 95%, 25g